Global Hybrid Positron Emission Tomography (PET) Systems Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2033

Hybrid Positron Emission Tomography (PET) Systems Market Size

• The global hybrid positron emission tomography (PET) systems market size was valued at USD 9.28 billion in 2025 and is expected to reach USD 15.01 billion by 2033, at a CAGR of 6.20% during the forecast period
• The market growth is largely fueled by the rising prevalence of cancer, neurological disorders, and cardiovascular diseases, along with continuous technological advancements in molecular imaging and diagnostic systems, leading to increased adoption of advanced imaging solutions across hospitals and diagnostic centers
• Furthermore, growing demand for early and accurate disease detection, increasing preference for hybrid imaging modalities combining functional and anatomical imaging, and expanding healthcare investments are establishing Hybrid Positron Emission Tomography (PET) Systems solutions as a critical component of modern diagnostic care. These converging factors are accelerating the uptake of Hybrid Positron Emission Tomography (PET) Systems solutions, thereby significantly boosting the industry's growth

Hybrid Positron Emission Tomography (PET) Systems Market Analysis

• Hybrid Positron Emission Tomography (PET) Systems solutions, including PET/CT systems, PET/MRI systems, oncology imaging platforms, cardiac imaging systems, and neurological diagnostic scanners, are increasingly vital components of modern healthcare due to their role in providing highly accurate functional and anatomical imaging for complex disease diagnosis and treatment planning
• The escalating demand for Hybrid Positron Emission Tomography (PET) Systems solutions is primarily fueled by rising incidence of cancer, neurological disorders, and cardiovascular diseases, increasing demand for early disease detection, growing use of precision medicine, and expanding investments in advanced diagnostic imaging infrastructure
• North America dominated the Hybrid Positron Emission Tomography (PET) Systems market with the largest revenue share of approximately 41.3% in 2025, characterized by advanced healthcare infrastructure, strong reimbursement systems, high adoption of cutting-edge imaging technologies, and the presence of leading medical device manufacturers, with the U.S. driving substantial demand for oncology and neurological imaging procedures
• Asia-Pacific is expected to be the fastest growing region in the Hybrid Positron Emission Tomography (PET) Systems market during the forecast period due to increasing healthcare expenditure, expanding hospital infrastructure, rising cancer burden, growing awareness of early diagnosis, and increasing installation of advanced imaging systems across China, India, Japan, South Korea, and Southeast Asia
• The Oncology segment dominated the largest market revenue share of 52.6% in 2025, driven by the increasing global burden of cancer and the growing need for accurate tumor detection, staging, and treatment monitoring

Report Scope and Hybrid Positron Emission Tomography (PET) Systems Market Segmentation

Hybrid Positron Emission Tomography (PET) Systems Market Trends

“Enhanced Diagnostic Accuracy Through AI-Assisted Imaging and Multimodal PET System Innovation”

• A significant and accelerating trend in the global Hybrid Positron Emission Tomography (PET) Systems market is the increasing adoption of AI-assisted image reconstruction, multimodal imaging platforms, and advanced detector technologies that improve diagnostic precision, workflow efficiency, and patient outcomes. These innovations are transforming molecular imaging worldwide.
• Integrated imaging systems are increasingly being used to combine anatomical and functional visualization for faster and more accurate diagnosis
• For instance, companies such as Siemens Healthineers, GE HealthCare, Philips, and Canon Medical offer advanced PET/CT and PET/MRI systems used in oncology, cardiology, and neurology applications globally
• The growing use of digital PET detectors, time-of-flight imaging, and low-dose scanning protocols is also improving image quality while reducing scan duration and radiation exposure
• Another major trend is the integration of AI-based lesion detection, automated quantification, and workflow management tools that help radiologists improve reporting efficiency
• In addition, rising investment in theranostics and precision medicine is increasing demand for hybrid PET systems capable of supporting targeted diagnostics and treatment monitoring
• This shift toward high-resolution, data-driven, and precision-focused imaging is fundamentally reshaping the global diagnostic imaging landscape

Hybrid Positron Emission Tomography (PET) Systems Market Dynamics

Driver

“Rising Cancer Burden and Growing Demand for Advanced Diagnostic Imaging”

• Increasing global prevalence of cancer, cardiovascular disease, and neurological disorders is a major driver for the Hybrid Positron Emission Tomography (PET) Systems market. Healthcare providers are expanding use of molecular imaging for early diagnosis, staging, and treatment response monitoring
• Growth in oncology imaging demand is further accelerating market expansion
• For instance, hospitals and imaging centers across the U.S., Germany, Japan, China, India, and Brazil are increasing procurement of PET/CT systems for lung cancer, lymphoma, breast cancer, and prostate cancer evaluations
• Rising adoption of personalized medicine and radiopharmaceutical-based diagnostics is also supporting demand for hybrid PET technologies
• Furthermore, improvements in reimbursement frameworks and healthcare infrastructure investments are encouraging installation of advanced imaging equipment
• Expanding clinical research in neurology, cardiology, and theranostics is expected to further strengthen market growth during the forecast period

Restraint/Challenge

“High Capital Costs, Limited Radiotracer Access, and Skilled Workforce Gaps”

• One of the major challenges restraining the Hybrid Positron Emission Tomography (PET) Systems market is the high capital expenditure associated with purchasing scanners, facility shielding, maintenance, and software upgrades, particularly for smaller hospitals and emerging markets.
• Limited access to radiotracers and cyclotron infrastructure can restrict utilization in many regions. For instance, healthcare facilities in parts of Africa, Southeast Asia, and rural Latin America may face delays or reduced PET scan availability due to short radiotracer shelf life and insufficient local production capacity
• Shortages of trained nuclear medicine physicians, radiologists, and technologists can also constrain efficient system adoption and throughput
• In addition, regulatory complexities surrounding radiopharmaceutical transport, licensing, and radiation safety increase operational burden
• Overcoming these barriers through lower-cost system models, expanded tracer production networks, workforce training, and supportive reimbursement policies will be essential for sustained market growth

Hybrid Positron Emission Tomography (PET) Systems Market Scope

The market is segmented on the basis of application and end user.

• By Application

On the basis of application, the Hybrid Positron Emission Tomography (PET) Systems market is segmented into Oncology, Radiology, Neurology, Ophthalmology, Cardiology, and Others. The Oncology segment dominated the largest market revenue share of 52.6% in 2025, driven by the increasing global burden of cancer and the growing need for accurate tumor detection, staging, and treatment monitoring. Hybrid PET systems are widely used in oncology because they combine functional and anatomical imaging for highly precise diagnosis. Rising adoption of PET/CT and PET/MRI technologies in cancer care centers further strengthens segment leadership. Increasing awareness regarding early cancer diagnosis is supporting demand. Expanding reimbursement coverage for oncology imaging procedures also contributes to growth. Technological advancements in radiotracers are improving scan efficiency and diagnostic accuracy. Growing investments in cancer treatment infrastructure continue to reinforce dominance.

The Neurology segment is expected to witness the fastest growth rate of 23.4% from 2026 to 2033, driven by rising prevalence of Alzheimer’s disease, Parkinson’s disease, epilepsy, and other neurological disorders. Hybrid PET systems help in early detection of brain abnormalities and functional assessment. Increasing aging populations across developed and emerging economies are boosting demand. Growing use of PET imaging in dementia diagnosis is accelerating segment expansion. Advancements in neuro-radiotracers are enhancing clinical applications. Research institutions are increasingly adopting PET systems for brain studies. Expanding awareness of early neurological screening is further supporting rapid growth.

• By End User

On the basis of end user, the Hybrid Positron Emission Tomography (PET) Systems market is segmented into Hospitals, Diagnostic Imaging Centers, and Others. The Hospitals segment held the largest market revenue share of 61.8% in 2025, driven by the presence of advanced imaging infrastructure, skilled radiologists, and integrated treatment facilities. Hospitals are primary centers for cancer diagnosis, cardiac evaluation, and neurological imaging using hybrid PET systems. Rising patient admissions and increasing preference for comprehensive in-house diagnostics support segment dominance. Growing investments in tertiary care hospitals are expanding installation rates. Availability of reimbursement-backed imaging procedures also strengthens adoption. Multi-specialty hospitals benefit from broad clinical use of PET systems across departments. Continuous modernization of hospital imaging departments supports sustained leadership.

The Diagnostic Imaging Centers segment is expected to witness the fastest CAGR of 22.7% from 2026 to 2033, driven by increasing demand for cost-effective and specialized outpatient imaging services. These centers offer faster appointments and focused diagnostic workflows, attracting both patients and referring physicians. Rising healthcare decentralization is supporting standalone imaging facility growth. Expansion of private diagnostic chains is increasing access to PET scans. Technological upgrades and installation of advanced PET/CT units are boosting competitiveness. Growing preventive health check trends are also supporting demand. Increasing collaborations with hospitals and oncology clinics continue to accelerate segment growth.

Hybrid Positron Emission Tomography (PET) Systems Market Regional Analysis

• North America dominated the hybrid positron emission tomography (PET) systems market with the largest revenue share of approximately 41.3% in 2025, characterized by advanced healthcare infrastructure, strong reimbursement systems, high adoption of cutting-edge imaging technologies, and the presence of leading medical device manufacturers. The region has also witnessed substantial demand for PET/CT and PET/MRI systems across oncology, cardiology, and neurological imaging applications
• Healthcare providers in the region highly value the superior diagnostic accuracy, early disease detection capabilities, and seamless integration offered by hybrid PET systems with advanced radiology workflows and digital imaging platforms. Increasing preference for precision diagnostics and image-guided treatment planning continues to strengthen market demand
• This widespread adoption is further supported by high healthcare spending, a technologically advanced clinical ecosystem, growing prevalence of cancer and neurological disorders, and increasing preference for non-invasive diagnostic imaging, establishing hybrid PET systems as a favored solution for hospitals, diagnostic centers, and research institutions

U.S. Hybrid Positron Emission Tomography (PET) Systems Market Insight

The U.S. hybrid positron emission tomography (PET) systems market captured the largest revenue share in 2025 within North America, fueled by strong adoption of advanced diagnostic imaging technologies and rising demand for precision medicine. Healthcare providers are increasingly prioritizing high-resolution PET/CT and PET/MRI systems for oncology staging, neurological assessments, and cardiovascular diagnostics. The growing preference for AI-assisted imaging workflows, combined with robust demand for outpatient imaging centers and mobile diagnostic services, further propels the market. Moreover, the increasing integration of smart healthcare technologies, such as cloud imaging platforms, automated analytics, and electronic health record connectivity, is significantly contributing to market expansion.

Europe Hybrid Positron Emission Tomography (PET) Systems Market Insight

The Europe hybrid positron emission tomography (PET) systems market is projected to expand at a substantial CAGR throughout the forecast period, primarily driven by rising cancer incidence, growing aging populations, and strong demand for accurate diagnostic imaging in hospitals and specialty centers. Increasing healthcare modernization, coupled with demand for advanced radiology equipment, is fostering the adoption of hybrid PET systems. European healthcare providers are also drawn to the efficiency, clinical precision, and lower long-term treatment costs these systems offer. The region is experiencing significant growth across public hospitals, private imaging centers, and academic institutions, with hybrid PET systems being incorporated into both new healthcare facilities and modernization projects.

U.K. Hybrid Positron Emission Tomography (PET) Systems Market Insight

The U.K. hybrid positron emission tomography (PET) systems market is anticipated to grow at a noteworthy CAGR during the forecast period, driven by increasing focus on early disease diagnosis and a desire for enhanced imaging capacity within healthcare systems. Additionally, concerns regarding cancer detection delays and rising neurological disorders are encouraging hospitals and clinics to invest in advanced PET imaging solutions. The UK’s embrace of connected healthcare technologies, alongside its robust clinical research infrastructure, is expected to continue to stimulate market growth.

Germany Hybrid Positron Emission Tomography (PET) Systems Market Insight

The Germany hybrid positron emission tomography (PET) systems market is expected to expand at a considerable CAGR during the forecast period, fueled by increasing awareness of early diagnosis, demand for technologically advanced imaging systems, and strong investment in healthcare modernization. Germany’s well-developed healthcare infrastructure, combined with its emphasis on innovation and clinical quality, promotes the adoption of hybrid PET systems, particularly in hospitals and specialty diagnostic centers. The integration of hybrid PET systems with digital imaging networks and AI-supported diagnostics is also becoming increasingly prevalent, with a strong preference for precise, privacy-focused solutions aligning with local clinical expectations.

Asia-Pacific Hybrid Positron Emission Tomography (PET) Systems Market Insight

The Asia-Pacific hybrid positron emission tomography (PET) systems market is poised to grow at the fastest CAGR during the forecast period of 2026 to 2033, driven by increasing healthcare expenditure, expanding hospital infrastructure, rising cancer burden, growing awareness of early diagnosis, and increasing installation of advanced imaging systems across China, India, Japan, South Korea, and Southeast Asia. The region's growing inclination towards modern healthcare technologies, supported by government initiatives promoting healthcare access, is driving adoption. Furthermore, as APAC emerges as a manufacturing hub for medical imaging equipment and components, the affordability and accessibility of hybrid PET systems are expanding to a wider patient base.

Japan Hybrid Positron Emission Tomography (PET) Systems Market Insight

The Japan hybrid positron emission tomography (PET) systems market is gaining momentum due to the country’s advanced healthcare technology base, aging population, and demand for accurate diagnostics. The Japanese market places a significant emphasis on early detection, and the adoption of hybrid PET systems is driven by the increasing number of cancer screening and neurological imaging procedures. The integration of hybrid PET systems with other digital healthcare technologies, such as AI imaging tools and hospital information systems, is fueling growth. Moreover, Japan's aging population is likely to spur demand for easier-to-access, high-precision diagnostic imaging solutions in both hospitals and specialty care centers.

China Hybrid Positron Emission Tomography (PET) Systems Market Insight

The China hybrid positron emission tomography (PET) systems market accounted for the largest market revenue share in Asia Pacific in 2025, attributed to the country's expanding healthcare infrastructure, rapid urbanization, and high rates of medical technology adoption. China stands as one of the largest markets for advanced imaging devices, and hybrid PET systems are becoming increasingly popular in tertiary hospitals, cancer centers, and private diagnostic chains. The push towards healthcare modernization and early cancer screening, alongside the availability of more affordable imaging solutions and strong domestic manufacturers, are key factors propelling market growth in China.

Hybrid Positron Emission Tomography (PET) Systems Market Share

The Hybrid Positron Emission Tomography (PET) Systems industry is primarily led by well-established companies, including:

• Siemens Healthineers AG (Germany)
• GE HealthCare Technologies Inc. (U.S.)
• Koninklijke Philips N.V. (Netherlands)
• Canon Medical Systems Corporation (Japan)
• United Imaging Healthcare Co., Ltd. (China)
• Mediso Ltd. (Hungary)
• Positron Corporation (U.S.)
• Shimadzu Corporation (Japan)
• Neusoft Medical Systems Co., Ltd. (China)
• Bruker Corporation (U.S.)
• Cubresa Inc. (Canada)
• Sofie Biosciences LLC (U.S.)
• MinFound Medical Systems Co., Ltd. (China)
• SurgicEye GmbH (Germany)
• MR Solutions Ltd. (U.K.)
• Molecubes NV (Belgium)
• CMR Naviscan Corporation (U.S.)
• Yangzhou Kindsway Biotech Co., Ltd. (China)
• Aspect Imaging Ltd. (Israel)
• Hitachi Healthcare Systems (Japan)

Latest Developments in Global Hybrid Positron Emission Tomography (PET) Systems Market

• In April 2023, ASSA ABLOY Group, a global leader in access solutions, launched a strategic initiative in South Africa aimed at strengthening the security of residential and commercial properties through its advanced Hybrid Positron Emission Tomography (PET) Systems technologies. This initiative underscores the company's dedication to delivering innovative, reliable access control solutions tailored to the unique security needs of the local market. By leveraging its global expertise and cutting-edge product offerings, ASSA ABLOY is not only addressing regional challenges but also reinforcing its position in the rapidly growing global Hybrid Positron Emission Tomography (PET) Systems market
• In March 2023, HavenLock Inc., a veteran-led company based in Tennessee, introduced the Power G version of its smart locking system, specifically engineered for schools and commercial environments. The innovative Haven Lockdown System is designed to enhance security protocols, offering a reliable and effective solution for emergency situations. This advancement highlights HavenLock's commitment to developing cutting-edge safety technologies that safeguard vulnerable spaces, ensuring greater protection and peace of mind for institutions and their communities
• In March 2023, Honeywell International Inc. successfully deployed the Bengaluru Safe City Project, aimed at enhancing urban safety through its advanced Hybrid Positron Emission Tomography (PET) Systems and security technologies. This initiative harnesses state-of-the-art solutions to create a more secure and resilient city environment, underscoring Honeywell's dedication to utilizing its expertise in innovative security systems. The project highlights the increasing significance of smart technology in urban safety, contributing to the development of safer, smarter communities
• In February 2023, Sentrilock, LLC, a leading provider of electronic lockbox solutions for the real estate industry, announced a strategic partnership with the Chesapeake Bay and Rivers Association of REALTORS (CBRAR) to create a smart electronic lockbox marketplace for REALTOR members. This collaboration is designed to enhance security and streamline accessibility for real estate professionals, facilitating more efficient and secure property transactions. The initiative underscores Sentrilock's commitment to driving innovation and improving operational effectiveness within the real estate sector
• In January 2023, Schlage, a leading provider of access and home security solutions under Allegion Plc, unveiled the Schlage Encode Smart Wi-Fi Lever at the NAHB International Builders’ Show (IBS) 2023. This innovative residential smart lock, equipped with Wi-Fi connectivity, enables users to manage access remotely through a dedicated app. The Schlage Encode lever highlights the company’s commitment to integrating advanced technology into home security systems, offering homeowners enhanced convenience and control while ensuring robust security

SKU-68017